Obducat (OBDU) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
5 Jun, 2025Executive summary
Revenue for Q4 2024 was 19.0 MSEK, down from 29.4 MSEK year-over-year; full-year revenue was 81.5 MSEK, down from 93.1 MSEK.
Operating result for Q4 was -5.4 MSEK (6.8 MSEK last year); full-year operating result was -5.4 MSEK (4.5 MSEK last year).
Order intake in Q4 rose to 25.1 MSEK (10.1 MSEK last year), but full-year order intake fell to 52.5 MSEK (117.9 MSEK last year).
Delays in component deliveries led to lower revenue and deferred cash flow; some expected 2024 revenue will be recognized in 2025.
Board calls for an extraordinary general meeting to decide on a 50 MSEK rights issue, 70% guaranteed.
Financial highlights
Q4 net income was -6.0 MSEK (2.7 MSEK last year); EPS was -0.04 SEK (0.02 SEK last year).
Full-year net income was -9.9 MSEK (0.8 MSEK last year); EPS was -0.06 SEK (0.01 SEK last year).
Q4 cash flow after investments was 5.4 MSEK (-3.7 MSEK last year); full-year cash flow after investments was 9.8 MSEK (-16.0 MSEK last year).
Year-end order backlog was 92.6 MSEK (123.6 MSEK last year).
Gross margin improved to 64% in Q4 (60% last year); full-year gross margin was 62% (56% last year).
Outlook and guidance
Market activity is increasing, with positive sentiment for 2025 and beyond; recovery expected to start late H1 2025.
Company plans to strengthen sales and support capacity and implement new operational methods in 2025.
Focus remains on customer satisfaction, innovation, and increased market visibility.
Latest events from Obducat
- Sharp revenue drop and operating loss in 2025; liquidity stabilized by rights issue in 2026.OBDU
Q4 202520 Feb 2026 - Sharp revenue drop and losses prompt new financing and strategic focus on 2026 recovery.OBDU
Q3 202514 Nov 2025 - Revenue and order intake fell significantly, with liquidity and financing risks remaining acute.OBDU
Q2 202525 Jul 2025 - Revenue up in Q3, but weak order intake and financing risks threaten ongoing operations.OBDU
Q3 202413 Jun 2025 - Revenue and margins improved in Q2, with higher order intake and a positive H2 outlook.OBDU
Q2 202413 Jun 2025 - Order intake rose and liquidity improved after a 35 MSEK rights issue, despite a wider Q1 loss.OBDU
Q1 20256 Jun 2025